Search for: "Dr. Reddy" Results 341 - 360 of 395
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Mar 2014, 9:17 am
Malathi Lakshmikumaran (Ph.D., FNASc, Patent Agent) & Prashant Reddy (B.A. [read post]
13 Jul 2011, 3:04 am by Marie Louise
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog)   Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine… [read post]
22 Dec 2016, 9:10 am by Brian Cordery
Sandoz focussed on “proportionality” and in particular the importance of the Court including consideration of “whether the injunction was proportionate and a legitimate barrier to trade”, citing Napp v Dr Reddy’s [2016] EWHC 1517 (Pat) and C-494/15 Tommy Hilfiger. [read post]
18 May 2011, 12:33 am by Marie Louise
Du Pont (EPLAW) Opana (Oxymorphone) – US: CAFC: important decision controlling BPAI obviousness holdings: In re Kao (Patently-O) (PharmaPatents) Silenor (Doxepin) – US: Somaxon sues Actavis over application to market generic Silenor (GenericsWeb) Tanakan (Ginko Biloba) – France: Mylan ordered to pay €17M to Ipsen for unfair competition by marketing Vitalogink to pharmacists as an “equivalent” to Tanakan (EPLAW) Valcyte (Valganciclovir) – US: Genentech files… [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
10 Nov 2010, 1:11 am by Kelly
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
20 Jun 2020, 1:57 pm by Alex Oliveira
In addition to Zantac, other manufacturers that produce prescription and OTC Ranitidine include: Sandoz Apotex Ajanta Pharma Aurobindo Pharma Dr. [read post]
11 Mar 2018, 7:27 pm by Nate Nead
Acquiring those organizations, or a disruptive drugmaker like Dr. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]